{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T21:27:27Z","timestamp":1771104447087,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jdcr.2023.01.013","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T02:40:07Z","timestamp":1675046407000},"page":"70-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Subacute cutaneous lupus erythematosus after mRNA-based SARS-CoV-2 vaccination"],"prefix":"10.1016","volume":"33","author":[{"given":"Sarah","family":"Rimmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Ly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Boh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jdcr.2023.01.013_bib1","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/j.1468-3083.2008.02806.x","article-title":"Pathogenesis of subacute cutaneous lupus erythematosus","volume":"22","author":"Stavropoulos","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jdcr.2023.01.013_bib2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/path.1721","article-title":"Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus","volume":"205","author":"Wenzel","year":"2005","journal-title":"J Pathol"},{"issue":"4","key":"10.1016\/j.jdcr.2023.01.013_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41577-021-00526-x","article-title":"COVID-19 vaccines: modes of immune activation and future challenges","volume":"21","author":"Teijaro","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jdcr.2023.01.013_bib4","doi-asserted-by":"crossref","first-page":"815743","DOI":"10.3389\/fmed.2022.815743","article-title":"Case report: Rowell syndrome\u2013like flare of cutaneous lupus erythematosus following COVID-19 infection","volume":"9","author":"Drenovska","year":"2022","journal-title":"Front Med"},{"issue":"1","key":"10.1016\/j.jdcr.2023.01.013_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/ced.14858","article-title":"Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA-based or adenoviral vector-based SARS-CoV-2 vaccination","volume":"47","author":"Kreuter","year":"2022","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.jdcr.2023.01.013_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15017","article-title":"Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine","volume":"34","author":"Niebel","year":"2021","journal-title":"Dermatol Ther"},{"issue":"7","key":"10.1016\/j.jdcr.2023.01.013_bib7","doi-asserted-by":"crossref","first-page":"e415","DOI":"10.1111\/jdv.17225","article-title":"Prompt onset of Rowell's syndrome following the first BNT162b2 SARS-CoV-2 vaccination","volume":"35","author":"Gambichler","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jdcr.2023.01.013_bib8","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.1111\/jdv.17895","article-title":"SCLE manifestation after mRNA COVID-19 vaccination","volume":"36","author":"Rechtien","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"10.1016\/j.jdcr.2023.01.013_bib9","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1001\/archderm.1994.01690100046006","article-title":"The autoantibody response to Ro\/SSA in cutaneous lupus erythematosus","volume":"130","author":"Lee","year":"1994","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.jdcr.2023.01.013_bib10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2340\/0001555577305308","article-title":"Markers in cutaneous lupus erythematosus indicating systemic involvement. A multicenter study on 296 patients","volume":"77","author":"Tebbe","year":"1997","journal-title":"Acta Derm Venereol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512623000255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512623000255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:24:39Z","timestamp":1762475079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512623000255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":10,"alternative-id":["S2352512623000255"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2023.01.013","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subacute cutaneous lupus erythematosus after mRNA-based SARS-CoV-2 vaccination","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2023.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier on behalf of the American Academy of Dermatology, Inc. This is an open access..","name":"copyright","label":"Copyright"}]}}